Exchange Traded Concepts, LLC Aura Biosciences, Inc. Transaction History

Exchange Traded Concepts, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$5.86 - $8.45 $574 - $828	98 Added 0.58%	16,895 $99,000
Q3 2024 Oct 10, 2024	SELL	$6.9 - $10.36 $85,104 - $127,780	-12,334 Reduced 42.34%	16,797 $149,000
Q2 2024 Aug 13, 2024	SELL	$6.81 - $7.89 $61,725 - $71,514	-9,064 Reduced 23.73%	29,131 $220,000
Q1 2024 Apr 15, 2024	BUY	$7.09 - $9.24 $165,168 - $215,255	23,296 Added 156.36%	38,195 $299,000
Q4 2023 Jan 05, 2024	BUY	$7.02 - $11.98 $26,521 - $45,260	3,778 Added 33.97%	14,899 $132,000

Q3 2023 Oct 18, 2023	SELL	$8.97 - $12.38 $2,735 - $3,775	-305 Reduced 2.67%	11,121 $99,000
Q2 2023 Jul 20, 2023	BUY	$8.51 - $13.33 $97,235 - $152,308	11,426 New	11,426 $141,000

107

52.1M

Ticker AURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,273,600
Market Cap $162M
Description
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.